HomeCompareEMFGF vs MRK

EMFGF vs MRK: Dividend Comparison 2026

EMFGF yields 3780.72% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMFGF wins by $4168142498932.90M in total portfolio value
10 years
EMFGF
EMFGF
● Live price
3780.72%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4168142498932.96M
Annual income
$3,961,995,313,029,420,000.00
Full EMFGF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — EMFGF vs MRK

📍 EMFGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMFGFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMFGF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EMFGF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMFGF
Annual income on $10K today (after 15% tax)
$321,361.06/yr
After 10yr DRIP, annual income (after tax)
$3,367,696,016,075,007,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, EMFGF beats the other by $3,367,696,016,074,999,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMFGF + MRK for your $10,000?

EMFGF: 50%MRK: 50%
100% MRK50/50100% EMFGF
Portfolio after 10yr
$2084071249466.51M
Annual income
$1,980,997,656,514,715,000.00/yr
Blended yield
95.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

EMFGF
No analyst data
Altman Z
-4.4
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMFGF buys
0
MRK buys
0
No recent congressional trades found for EMFGF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMFGFMRK
Forward yield3780.72%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$4168142498932.96M$56.8K
Annual income after 10y$3,961,995,313,029,420,000.00$9,798.13
Total dividends collected$4154047075985.46M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EMFGF vs MRK ($10,000, DRIP)

YearEMFGF PortfolioEMFGF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$388,772$378,071.83$11,206$366.19+$377.6KEMFGF
2$14,152,778$13,736,792.53$12,650$502.35+$14.14MEMFGF
3$482,500,174$467,356,701.55$14,407$694.19+$482.49MEMFGF
4$15,407,158,664$14,890,883,477.51$16,585$967.82+$15407.14MEMFGF
5$460,873,091,761$444,387,431,989.88$19,342$1,363.89+$460873.07MEMFGF
6$12,916,428,912,197$12,423,294,704,013.35$22,913$1,947.19+$12916428.89MEMFGF
7$339,218,006,728,917$325,397,427,792,866.06$27,662$2,823.89+$339218006.70MEMFGF
8$8,349,652,345,953,757$7,986,689,078,753,816.00$34,159$4,173.35+$8349652345.92MEMFGF
9$192,660,921,405,176,800$183,726,793,395,006,270.00$43,337$6,308.80+$192660921405.13MEMFGF
10$4,168,142,498,932,959,000$3,961,995,313,029,420,000.00$56,776$9,798.13+$4168142498932.90MEMFGF

EMFGF vs MRK: Complete Analysis 2026

EMFGFStock

Fluence Corporation Limited provides water and wastewater treatment, and reuse solutions for the municipal, commercial, and industrial markets worldwide. The company offers NIROBOX for desalination of seawater and brackish water, as well as for the treatment of fresh and wastewater; NIROFLEX systems for desalination, ultrafiltration and multimedia filtration systems, and reverse osmosis systems. It also provides wastewater treatment products, such as Aspiral, a wastewater treatment solution; SUBRE membrane aerated biofilm reactor modules; EcoBox water reuse systems; Tipton packaged wastewater treatment plants; aeration equipment comprising aerators, mixers, and diffusers; and dissolved air flotation systems. In addition, the company offers food and beverage processing and recovery solutions; and waste-to-energy solutions. Further, it provides project finance, Smart Operations data analytics software, and after-sale support services. Fluence Corporation Limited was incorporated in 2007 and is headquartered in White Plains, New York.

Full EMFGF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this EMFGF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMFGF vs SCHDEMFGF vs JEPIEMFGF vs OEMFGF vs KOEMFGF vs MAINEMFGF vs JNJEMFGF vs ABBVEMFGF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.